Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Livzon Pharmaceutical Group ( (HK:1513) ) has issued an announcement.
Livzon Pharmaceutical Group Inc. has announced the composition of its board of directors and the membership of its board committees. This announcement provides clarity on the leadership structure of the company, which could influence its strategic direction and governance practices, potentially impacting stakeholders and the company’s market positioning.
The most recent analyst rating on (HK:1513) stock is a Sell with a HK$24.00 price target. To see the full list of analyst forecasts on Livzon Pharmaceutical Group stock, see the HK:1513 Stock Forecast page.
More about Livzon Pharmaceutical Group
Livzon Pharmaceutical Group Inc. operates in the pharmaceutical industry, focusing on the development, production, and distribution of pharmaceutical products. The company is known for its comprehensive range of healthcare solutions, catering to various market needs.
Average Trading Volume: 1,090,004
Technical Sentiment Signal: Buy
Current Market Cap: HK$31.19B
For an in-depth examination of 1513 stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue